We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mathematical Model Validated Experimentally

By Biotechdaily staff writers
Posted on 08 Feb 2005
Researchers have shown experimentally that a mathematical model for sphingomyelin metabolism in yeast accurately predicts the biochemical events taking place within the cell.

Many cell biologists feel that mathematical models are now necessary tools for organizing the rapidly increasing amounts of large-scale data on biochemical pathways and for advanced evaluation of their structure and regulation. More...
However, it has proven difficult to demonstrate experimentally the validity of mathematical models.

In the current study, published in the January 27, 2005, issue of Nature, investigators at the Medical University of South Carolina (Charleston, USA; www.musc.edu) and the Georgia Institute of Technology (Atlanta, USA; www.gatech.edu) demonstrated the experimental validation of a mathematical model for sphingomyelin metabolism in yeast. As the metabolic pathway in yeast is similar to that in humans, the authors feel that their results represent a good starting point for modeling this pathway in humans.

"This model now allows us to test ‘what-if' scenarios and make predictions on experiments that have not been performed or that are very difficult or impossible to perform,” explained contributing author Dr. Eberhard Voit, professor of biomedical engineering at the Georgia Institute of Technology. "Qualitatively, all of our predictions were correct. If we predicted an increase in something, the experiments showed a similar increase. Quantitatively, our predictions need to be refined further. If we had a human model of the current quality, we would still not be able, for instance, to predict with sufficient reliability the drug dosage needed for treating a specific disease process.”





Related Links:
Medical University of South Carolina
Georgia Institute of Technology

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Pipette Calibration System
Artel PCS®
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.